nodes	percent_of_prediction	percent_of_DWPC	metapath
Terbutaline—BCHE—Ramipril—type 2 diabetes mellitus	0.483	1	CbGbCtD
Terbutaline—Isoprenaline—PIK3R1—type 2 diabetes mellitus	0.00332	0.194	CrCbGaD
Terbutaline—Fenoterol—ADRB3—type 2 diabetes mellitus	0.00245	0.144	CrCbGaD
Terbutaline—Clenbuterol—ADRB3—type 2 diabetes mellitus	0.0024	0.14	CrCbGaD
Terbutaline—Bupranolol—ADRB3—type 2 diabetes mellitus	0.00237	0.139	CrCbGaD
Terbutaline—Cramp muscle—Metformin—type 2 diabetes mellitus	0.00166	0.00432	CcSEcCtD
Terbutaline—Rash—Tolbutamide—type 2 diabetes mellitus	0.00164	0.00426	CcSEcCtD
Terbutaline—Anxiety—Glipizide—type 2 diabetes mellitus	0.00163	0.00424	CcSEcCtD
Terbutaline—Sweating—Gliclazide—type 2 diabetes mellitus	0.00163	0.00424	CcSEcCtD
Terbutaline—Headache—Tolbutamide—type 2 diabetes mellitus	0.00163	0.00423	CcSEcCtD
Terbutaline—Tension—Bromocriptine—type 2 diabetes mellitus	0.00159	0.00413	CcSEcCtD
Terbutaline—Palpitations—Glimepiride—type 2 diabetes mellitus	0.00159	0.00412	CcSEcCtD
Terbutaline—Asthenia—Nateglinide—type 2 diabetes mellitus	0.00157	0.00409	CcSEcCtD
Terbutaline—Nervousness—Bromocriptine—type 2 diabetes mellitus	0.00157	0.00409	CcSEcCtD
Terbutaline—Cramp muscle—Irbesartan—type 2 diabetes mellitus	0.00157	0.00408	CcSEcCtD
Terbutaline—Chest pain—Pioglitazone—type 2 diabetes mellitus	0.00157	0.00407	CcSEcCtD
Terbutaline—Dizziness—Chlorpropamide—type 2 diabetes mellitus	0.00157	0.00406	CcSEcCtD
Terbutaline—Dizziness—Tolazamide—type 2 diabetes mellitus	0.00157	0.00406	CcSEcCtD
Terbutaline—Muscle spasms—Bromocriptine—type 2 diabetes mellitus	0.00156	0.00404	CcSEcCtD
Terbutaline—Nausea—Tolbutamide—type 2 diabetes mellitus	0.00155	0.00401	CcSEcCtD
Terbutaline—Anxiety—Glimepiride—type 2 diabetes mellitus	0.00152	0.00396	CcSEcCtD
Terbutaline—Anxiety—Sitagliptin—type 2 diabetes mellitus	0.00152	0.00394	CcSEcCtD
Terbutaline—Hyperhidrosis—Glipizide—type 2 diabetes mellitus	0.00152	0.00394	CcSEcCtD
Terbutaline—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.00151	0.00391	CcSEcCtD
Terbutaline—Dry mouth—Glimepiride—type 2 diabetes mellitus	0.0015	0.00388	CcSEcCtD
Terbutaline—Rash—Chlorpropamide—type 2 diabetes mellitus	0.00149	0.00388	CcSEcCtD
Terbutaline—Rash—Tolazamide—type 2 diabetes mellitus	0.00149	0.00388	CcSEcCtD
Terbutaline—Dry mouth—Sitagliptin—type 2 diabetes mellitus	0.00149	0.00387	CcSEcCtD
Terbutaline—Headache—Tolazamide—type 2 diabetes mellitus	0.00148	0.00385	CcSEcCtD
Terbutaline—Headache—Chlorpropamide—type 2 diabetes mellitus	0.00148	0.00385	CcSEcCtD
Terbutaline—Cramp muscle—Losartan—type 2 diabetes mellitus	0.00148	0.00384	CcSEcCtD
Terbutaline—Rash—Linagliptin—type 2 diabetes mellitus	0.00148	0.00384	CcSEcCtD
Terbutaline—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.00148	0.00383	CcSEcCtD
Terbutaline—Headache—Linagliptin—type 2 diabetes mellitus	0.00147	0.00381	CcSEcCtD
Terbutaline—Hyperhidrosis—Pioglitazone—type 2 diabetes mellitus	0.00145	0.00378	CcSEcCtD
Terbutaline—Dizziness—Nateglinide—type 2 diabetes mellitus	0.00145	0.00377	CcSEcCtD
Terbutaline—Vomiting—Acarbose—type 2 diabetes mellitus	0.00145	0.00375	CcSEcCtD
Terbutaline—Rash—Acarbose—type 2 diabetes mellitus	0.00143	0.00372	CcSEcCtD
Terbutaline—Dermatitis—Acarbose—type 2 diabetes mellitus	0.00143	0.00372	CcSEcCtD
Terbutaline—Tachycardia—Glimepiride—type 2 diabetes mellitus	0.00143	0.00371	CcSEcCtD
Terbutaline—Drowsiness—Metformin—type 2 diabetes mellitus	0.00142	0.0037	CcSEcCtD
Terbutaline—Insomnia—Glipizide—type 2 diabetes mellitus	0.00142	0.00369	CcSEcCtD
Terbutaline—Flushing—Gliclazide—type 2 diabetes mellitus	0.00142	0.00368	CcSEcCtD
Terbutaline—Hyperhidrosis—Glimepiride—type 2 diabetes mellitus	0.00142	0.00368	CcSEcCtD
Terbutaline—Paraesthesia—Glipizide—type 2 diabetes mellitus	0.00141	0.00366	CcSEcCtD
Terbutaline—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.00141	0.00365	CcSEcCtD
Terbutaline—Nausea—Tolazamide—type 2 diabetes mellitus	0.00141	0.00365	CcSEcCtD
Terbutaline—Dyspnoea—Glipizide—type 2 diabetes mellitus	0.0014	0.00364	CcSEcCtD
Terbutaline—Somnolence—Glipizide—type 2 diabetes mellitus	0.0014	0.00362	CcSEcCtD
Terbutaline—Vomiting—Nateglinide—type 2 diabetes mellitus	0.00139	0.00362	CcSEcCtD
Terbutaline—Tremor—Glyburide—type 2 diabetes mellitus	0.00139	0.0036	CcSEcCtD
Terbutaline—Rash—Nateglinide—type 2 diabetes mellitus	0.00138	0.00359	CcSEcCtD
Terbutaline—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.00138	0.00359	CcSEcCtD
Terbutaline—Anxiety—Bromocriptine—type 2 diabetes mellitus	0.00137	0.00357	CcSEcCtD
Terbutaline—Insomnia—Pioglitazone—type 2 diabetes mellitus	0.00136	0.00353	CcSEcCtD
Terbutaline—Nausea—Acarbose—type 2 diabetes mellitus	0.00135	0.00351	CcSEcCtD
Terbutaline—Dry mouth—Bromocriptine—type 2 diabetes mellitus	0.00135	0.0035	CcSEcCtD
Terbutaline—Dyspnoea—Pioglitazone—type 2 diabetes mellitus	0.00134	0.00348	CcSEcCtD
Terbutaline—Insomnia—Glimepiride—type 2 diabetes mellitus	0.00133	0.00344	CcSEcCtD
Terbutaline—Insomnia—Sitagliptin—type 2 diabetes mellitus	0.00132	0.00343	CcSEcCtD
Terbutaline—Paraesthesia—Glimepiride—type 2 diabetes mellitus	0.00132	0.00342	CcSEcCtD
Terbutaline—Dyspnoea—Glimepiride—type 2 diabetes mellitus	0.00131	0.00339	CcSEcCtD
Terbutaline—Tension—Gliclazide—type 2 diabetes mellitus	0.0013	0.00339	CcSEcCtD
Terbutaline—Somnolence—Glimepiride—type 2 diabetes mellitus	0.0013	0.00338	CcSEcCtD
Terbutaline—Nausea—Nateglinide—type 2 diabetes mellitus	0.0013	0.00338	CcSEcCtD
Terbutaline—Somnolence—Sitagliptin—type 2 diabetes mellitus	0.0013	0.00337	CcSEcCtD
Terbutaline—Nervousness—Gliclazide—type 2 diabetes mellitus	0.00129	0.00335	CcSEcCtD
Terbutaline—Tachycardia—Bromocriptine—type 2 diabetes mellitus	0.00129	0.00335	CcSEcCtD
Terbutaline—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.00129	0.00334	CcSEcCtD
Terbutaline—Cramp muscle—Ramipril—type 2 diabetes mellitus	0.00127	0.00329	CcSEcCtD
Terbutaline—Tremor—Gliclazide—type 2 diabetes mellitus	0.00125	0.00323	CcSEcCtD
Terbutaline—Sweating—Losartan—type 2 diabetes mellitus	0.00121	0.00315	CcSEcCtD
Terbutaline—Vomiting—Repaglinide—type 2 diabetes mellitus	0.00121	0.00313	CcSEcCtD
Terbutaline—Isoprenaline—ADRB3—type 2 diabetes mellitus	0.0012	0.0701	CrCbGaD
Terbutaline—Rash—Repaglinide—type 2 diabetes mellitus	0.0012	0.00311	CcSEcCtD
Terbutaline—Insomnia—Bromocriptine—type 2 diabetes mellitus	0.0012	0.0031	CcSEcCtD
Terbutaline—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.0012	0.0031	CcSEcCtD
Terbutaline—Headache—Repaglinide—type 2 diabetes mellitus	0.00119	0.00309	CcSEcCtD
Terbutaline—Paraesthesia—Bromocriptine—type 2 diabetes mellitus	0.00119	0.00308	CcSEcCtD
Terbutaline—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.00119	0.00308	CcSEcCtD
Terbutaline—Flushing—Metformin—type 2 diabetes mellitus	0.00119	0.00308	CcSEcCtD
Terbutaline—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.00118	0.00306	CcSEcCtD
Terbutaline—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.00118	0.00305	CcSEcCtD
Terbutaline—Palpitations—Gliclazide—type 2 diabetes mellitus	0.00118	0.00305	CcSEcCtD
Terbutaline—Muscle spasms—Valsartan—type 2 diabetes mellitus	0.00117	0.00305	CcSEcCtD
Terbutaline—Hyperhidrosis—Glyburide—type 2 diabetes mellitus	0.00117	0.00303	CcSEcCtD
Terbutaline—Muscle spasms—Orlistat—type 2 diabetes mellitus	0.00116	0.00301	CcSEcCtD
Terbutaline—Chest pain—Gliclazide—type 2 diabetes mellitus	0.00113	0.00294	CcSEcCtD
Terbutaline—Rash—Rosiglitazone—type 2 diabetes mellitus	0.00113	0.00294	CcSEcCtD
Terbutaline—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.00113	0.00293	CcSEcCtD
Terbutaline—Anxiety—Gliclazide—type 2 diabetes mellitus	0.00113	0.00293	CcSEcCtD
Terbutaline—Nausea—Repaglinide—type 2 diabetes mellitus	0.00113	0.00293	CcSEcCtD
Terbutaline—Asthenia—Glipizide—type 2 diabetes mellitus	0.00113	0.00293	CcSEcCtD
Terbutaline—Headache—Rosiglitazone—type 2 diabetes mellitus	0.00112	0.00292	CcSEcCtD
Terbutaline—Flushing—Irbesartan—type 2 diabetes mellitus	0.00112	0.00291	CcSEcCtD
Terbutaline—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.00111	0.00287	CcSEcCtD
Terbutaline—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.00109	0.00282	CcSEcCtD
Terbutaline—Palpitations—Valsartan—type 2 diabetes mellitus	0.00108	0.0028	CcSEcCtD
Terbutaline—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.00108	0.0028	CcSEcCtD
Terbutaline—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.00108	0.0028	CcSEcCtD
Terbutaline—Muscle spasms—Metformin—type 2 diabetes mellitus	0.00107	0.00278	CcSEcCtD
Terbutaline—Palpitations—Orlistat—type 2 diabetes mellitus	0.00107	0.00277	CcSEcCtD
Terbutaline—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00107	0.00277	CcSEcCtD
Terbutaline—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.00106	0.00275	CcSEcCtD
Terbutaline—Flushing—Losartan—type 2 diabetes mellitus	0.00105	0.00274	CcSEcCtD
Terbutaline—Asthenia—Glimepiride—type 2 diabetes mellitus	0.00105	0.00273	CcSEcCtD
Terbutaline—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.00105	0.00272	CcSEcCtD
Terbutaline—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.00105	0.00272	CcSEcCtD
Terbutaline—Tremor—Metformin—type 2 diabetes mellitus	0.00104	0.00271	CcSEcCtD
Terbutaline—Chest pain—Valsartan—type 2 diabetes mellitus	0.00104	0.0027	CcSEcCtD
Terbutaline—Sweating—Ramipril—type 2 diabetes mellitus	0.00104	0.0027	CcSEcCtD
Terbutaline—Dizziness—Glipizide—type 2 diabetes mellitus	0.00104	0.0027	CcSEcCtD
Terbutaline—Anxiety—Valsartan—type 2 diabetes mellitus	0.00104	0.00269	CcSEcCtD
Terbutaline—Tension—Irbesartan—type 2 diabetes mellitus	0.00103	0.00268	CcSEcCtD
Terbutaline—Clenbuterol—TNF—type 2 diabetes mellitus	0.00103	0.0602	CrCbGaD
Terbutaline—Chest pain—Orlistat—type 2 diabetes mellitus	0.00103	0.00267	CcSEcCtD
Terbutaline—Anxiety—Orlistat—type 2 diabetes mellitus	0.00102	0.00266	CcSEcCtD
Terbutaline—Nervousness—Irbesartan—type 2 diabetes mellitus	0.00102	0.00265	CcSEcCtD
Terbutaline—Dry mouth—Valsartan—type 2 diabetes mellitus	0.00102	0.00264	CcSEcCtD
Terbutaline—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.00101	0.00262	CcSEcCtD
Terbutaline—Epinephrine—ADRB3—type 2 diabetes mellitus	0.00101	0.0589	CrCbGaD
Terbutaline—Dry mouth—Orlistat—type 2 diabetes mellitus	0.00101	0.00261	CcSEcCtD
Terbutaline—Vomiting—Glipizide—type 2 diabetes mellitus	0.000999	0.00259	CcSEcCtD
Terbutaline—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000995	0.00258	CcSEcCtD
Terbutaline—Rash—Glipizide—type 2 diabetes mellitus	0.00099	0.00257	CcSEcCtD
Terbutaline—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000989	0.00257	CcSEcCtD
Terbutaline—Headache—Glipizide—type 2 diabetes mellitus	0.000984	0.00255	CcSEcCtD
Terbutaline—Tremor—Irbesartan—type 2 diabetes mellitus	0.000984	0.00255	CcSEcCtD
Terbutaline—Palpitations—Metformin—type 2 diabetes mellitus	0.000983	0.00255	CcSEcCtD
Terbutaline—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000982	0.00255	CcSEcCtD
Terbutaline—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000975	0.00253	CcSEcCtD
Terbutaline—Tension—Losartan—type 2 diabetes mellitus	0.00097	0.00252	CcSEcCtD
Terbutaline—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000969	0.00252	CcSEcCtD
Terbutaline—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000968	0.00251	CcSEcCtD
Terbutaline—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000966	0.00251	CcSEcCtD
Terbutaline—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000965	0.00251	CcSEcCtD
Terbutaline—Nervousness—Losartan—type 2 diabetes mellitus	0.00096	0.00249	CcSEcCtD
Terbutaline—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000952	0.00247	CcSEcCtD
Terbutaline—Muscle spasms—Losartan—type 2 diabetes mellitus	0.00095	0.00247	CcSEcCtD
Terbutaline—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000949	0.00246	CcSEcCtD
Terbutaline—Chest pain—Metformin—type 2 diabetes mellitus	0.000947	0.00246	CcSEcCtD
Terbutaline—Headache—Pioglitazone—type 2 diabetes mellitus	0.000943	0.00245	CcSEcCtD
Terbutaline—Nausea—Glipizide—type 2 diabetes mellitus	0.000933	0.00242	CcSEcCtD
Terbutaline—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000932	0.00242	CcSEcCtD
Terbutaline—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000929	0.00241	CcSEcCtD
Terbutaline—Tremor—Losartan—type 2 diabetes mellitus	0.000926	0.0024	CcSEcCtD
Terbutaline—Rash—Glimepiride—type 2 diabetes mellitus	0.000924	0.0024	CcSEcCtD
Terbutaline—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000923	0.0024	CcSEcCtD
Terbutaline—Rash—Sitagliptin—type 2 diabetes mellitus	0.000921	0.00239	CcSEcCtD
Terbutaline—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00092	0.00239	CcSEcCtD
Terbutaline—Headache—Glimepiride—type 2 diabetes mellitus	0.000918	0.00238	CcSEcCtD
Terbutaline—Headache—Sitagliptin—type 2 diabetes mellitus	0.000915	0.00238	CcSEcCtD
Terbutaline—Flushing—Ramipril—type 2 diabetes mellitus	0.000903	0.00235	CcSEcCtD
Terbutaline—Insomnia—Valsartan—type 2 diabetes mellitus	0.000902	0.00234	CcSEcCtD
Terbutaline—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000895	0.00232	CcSEcCtD
Terbutaline—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000894	0.00232	CcSEcCtD
Terbutaline—Insomnia—Orlistat—type 2 diabetes mellitus	0.000891	0.00231	CcSEcCtD
Terbutaline—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000891	0.00231	CcSEcCtD
Terbutaline—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000889	0.00231	CcSEcCtD
Terbutaline—Somnolence—Valsartan—type 2 diabetes mellitus	0.000886	0.0023	CcSEcCtD
Terbutaline—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000885	0.0023	CcSEcCtD
Terbutaline—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000878	0.00228	CcSEcCtD
Terbutaline—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000874	0.00227	CcSEcCtD
Terbutaline—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000874	0.00227	CcSEcCtD
Terbutaline—Palpitations—Losartan—type 2 diabetes mellitus	0.000873	0.00227	CcSEcCtD
Terbutaline—Nausea—Glimepiride—type 2 diabetes mellitus	0.000871	0.00226	CcSEcCtD
Terbutaline—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000868	0.00225	CcSEcCtD
Terbutaline—Asthenia—Glyburide—type 2 diabetes mellitus	0.000867	0.00225	CcSEcCtD
Terbutaline—Chest pain—Losartan—type 2 diabetes mellitus	0.000841	0.00218	CcSEcCtD
Terbutaline—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000841	0.00218	CcSEcCtD
Terbutaline—Anxiety—Losartan—type 2 diabetes mellitus	0.000838	0.00218	CcSEcCtD
Terbutaline—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000836	0.00217	CcSEcCtD
Terbutaline—Rash—Bromocriptine—type 2 diabetes mellitus	0.000834	0.00216	CcSEcCtD
Terbutaline—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000833	0.00216	CcSEcCtD
Terbutaline—Tension—Ramipril—type 2 diabetes mellitus	0.000831	0.00216	CcSEcCtD
Terbutaline—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000828	0.00215	CcSEcCtD
Terbutaline—Headache—Bromocriptine—type 2 diabetes mellitus	0.000828	0.00215	CcSEcCtD
Terbutaline—Nervousness—Ramipril—type 2 diabetes mellitus	0.000823	0.00214	CcSEcCtD
Terbutaline—Dry mouth—Losartan—type 2 diabetes mellitus	0.000823	0.00214	CcSEcCtD
Terbutaline—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000815	0.00212	CcSEcCtD
Terbutaline—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000815	0.00211	CcSEcCtD
Terbutaline—Dyspnoea—Metformin—type 2 diabetes mellitus	0.00081	0.0021	CcSEcCtD
Terbutaline—Somnolence—Metformin—type 2 diabetes mellitus	0.000807	0.0021	CcSEcCtD
Terbutaline—Tremor—Ramipril—type 2 diabetes mellitus	0.000794	0.00206	CcSEcCtD
Terbutaline—Tachycardia—Losartan—type 2 diabetes mellitus	0.000787	0.00204	CcSEcCtD
Terbutaline—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000785	0.00204	CcSEcCtD
Terbutaline—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.00078	0.00202	CcSEcCtD
Terbutaline—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000779	0.00202	CcSEcCtD
Terbutaline—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000769	0.002	CcSEcCtD
Terbutaline—Vomiting—Glyburide—type 2 diabetes mellitus	0.000768	0.002	CcSEcCtD
Terbutaline—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000764	0.00198	CcSEcCtD
Terbutaline—Rash—Glyburide—type 2 diabetes mellitus	0.000762	0.00198	CcSEcCtD
Terbutaline—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000762	0.00198	CcSEcCtD
Terbutaline—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000761	0.00198	CcSEcCtD
Terbutaline—Headache—Glyburide—type 2 diabetes mellitus	0.000757	0.00197	CcSEcCtD
Terbutaline—Clenbuterol—CYP1A2—type 2 diabetes mellitus	0.000754	0.0441	CrCbGaD
Terbutaline—Palpitations—Ramipril—type 2 diabetes mellitus	0.000749	0.00194	CcSEcCtD
Terbutaline—Insomnia—Losartan—type 2 diabetes mellitus	0.000729	0.00189	CcSEcCtD
Terbutaline—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000724	0.00188	CcSEcCtD
Terbutaline—Chest pain—Ramipril—type 2 diabetes mellitus	0.000721	0.00187	CcSEcCtD
Terbutaline—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000719	0.00187	CcSEcCtD
Terbutaline—Anxiety—Ramipril—type 2 diabetes mellitus	0.000719	0.00187	CcSEcCtD
Terbutaline—Nausea—Glyburide—type 2 diabetes mellitus	0.000718	0.00186	CcSEcCtD
Terbutaline—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000718	0.00186	CcSEcCtD
Terbutaline—Somnolence—Losartan—type 2 diabetes mellitus	0.000717	0.00186	CcSEcCtD
Terbutaline—Asthenia—Valsartan—type 2 diabetes mellitus	0.000715	0.00186	CcSEcCtD
Terbutaline—Asthenia—Orlistat—type 2 diabetes mellitus	0.000707	0.00184	CcSEcCtD
Terbutaline—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000705	0.00183	CcSEcCtD
Terbutaline—Vomiting—Gliclazide—type 2 diabetes mellitus	0.00069	0.00179	CcSEcCtD
Terbutaline—Rash—Gliclazide—type 2 diabetes mellitus	0.000684	0.00178	CcSEcCtD
Terbutaline—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000684	0.00178	CcSEcCtD
Terbutaline—Phenylephrine—CYP1A2—type 2 diabetes mellitus	0.000682	0.0399	CrCbGaD
Terbutaline—Headache—Gliclazide—type 2 diabetes mellitus	0.00068	0.00177	CcSEcCtD
Terbutaline—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000675	0.00175	CcSEcCtD
Terbutaline—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000668	0.00174	CcSEcCtD
Terbutaline—Dizziness—Valsartan—type 2 diabetes mellitus	0.000659	0.00171	CcSEcCtD
Terbutaline—Dizziness—Orlistat—type 2 diabetes mellitus	0.000652	0.00169	CcSEcCtD
Terbutaline—Asthenia—Metformin—type 2 diabetes mellitus	0.000651	0.00169	CcSEcCtD
Terbutaline—Nausea—Gliclazide—type 2 diabetes mellitus	0.000645	0.00167	CcSEcCtD
Terbutaline—Vomiting—Valsartan—type 2 diabetes mellitus	0.000634	0.00165	CcSEcCtD
Terbutaline—Rash—Valsartan—type 2 diabetes mellitus	0.000629	0.00163	CcSEcCtD
Terbutaline—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000628	0.00163	CcSEcCtD
Terbutaline—Vomiting—Orlistat—type 2 diabetes mellitus	0.000626	0.00163	CcSEcCtD
Terbutaline—Insomnia—Ramipril—type 2 diabetes mellitus	0.000625	0.00162	CcSEcCtD
Terbutaline—Headache—Valsartan—type 2 diabetes mellitus	0.000625	0.00162	CcSEcCtD
Terbutaline—Rash—Orlistat—type 2 diabetes mellitus	0.000621	0.00161	CcSEcCtD
Terbutaline—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000621	0.00161	CcSEcCtD
Terbutaline—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000621	0.00161	CcSEcCtD
Terbutaline—Headache—Orlistat—type 2 diabetes mellitus	0.000617	0.0016	CcSEcCtD
Terbutaline—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000616	0.0016	CcSEcCtD
Terbutaline—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000615	0.0016	CcSEcCtD
Terbutaline—Somnolence—Ramipril—type 2 diabetes mellitus	0.000615	0.0016	CcSEcCtD
Terbutaline—Dizziness—Metformin—type 2 diabetes mellitus	0.0006	0.00156	CcSEcCtD
Terbutaline—Nausea—Valsartan—type 2 diabetes mellitus	0.000592	0.00154	CcSEcCtD
Terbutaline—Nausea—Orlistat—type 2 diabetes mellitus	0.000585	0.00152	CcSEcCtD
Terbutaline—Asthenia—Losartan—type 2 diabetes mellitus	0.000579	0.0015	CcSEcCtD
Terbutaline—Vomiting—Metformin—type 2 diabetes mellitus	0.000577	0.0015	CcSEcCtD
Terbutaline—Rash—Metformin—type 2 diabetes mellitus	0.000573	0.00149	CcSEcCtD
Terbutaline—Dermatitis—Metformin—type 2 diabetes mellitus	0.000572	0.00149	CcSEcCtD
Terbutaline—Headache—Metformin—type 2 diabetes mellitus	0.000569	0.00148	CcSEcCtD
Terbutaline—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000567	0.00147	CcSEcCtD
Terbutaline—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000545	0.00141	CcSEcCtD
Terbutaline—Rash—Irbesartan—type 2 diabetes mellitus	0.00054	0.0014	CcSEcCtD
Terbutaline—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.00054	0.0014	CcSEcCtD
Terbutaline—Nausea—Metformin—type 2 diabetes mellitus	0.000539	0.0014	CcSEcCtD
Terbutaline—Headache—Irbesartan—type 2 diabetes mellitus	0.000537	0.00139	CcSEcCtD
Terbutaline—Dizziness—Losartan—type 2 diabetes mellitus	0.000533	0.00138	CcSEcCtD
Terbutaline—Vomiting—Losartan—type 2 diabetes mellitus	0.000513	0.00133	CcSEcCtD
Terbutaline—Nausea—Irbesartan—type 2 diabetes mellitus	0.000509	0.00132	CcSEcCtD
Terbutaline—Rash—Losartan—type 2 diabetes mellitus	0.000508	0.00132	CcSEcCtD
Terbutaline—Dermatitis—Losartan—type 2 diabetes mellitus	0.000508	0.00132	CcSEcCtD
Terbutaline—Headache—Losartan—type 2 diabetes mellitus	0.000505	0.00131	CcSEcCtD
Terbutaline—Asthenia—Ramipril—type 2 diabetes mellitus	0.000496	0.00129	CcSEcCtD
Terbutaline—Nausea—Losartan—type 2 diabetes mellitus	0.000479	0.00124	CcSEcCtD
Terbutaline—Salbutamol—CYP3A4—type 2 diabetes mellitus	0.000464	0.0271	CrCbGaD
Terbutaline—Dizziness—Ramipril—type 2 diabetes mellitus	0.000457	0.00119	CcSEcCtD
Terbutaline—Epinephrine—ADRA2A—type 2 diabetes mellitus	0.000456	0.0267	CrCbGaD
Terbutaline—Vomiting—Ramipril—type 2 diabetes mellitus	0.00044	0.00114	CcSEcCtD
Terbutaline—Rash—Ramipril—type 2 diabetes mellitus	0.000436	0.00113	CcSEcCtD
Terbutaline—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000436	0.00113	CcSEcCtD
Terbutaline—Headache—Ramipril—type 2 diabetes mellitus	0.000433	0.00112	CcSEcCtD
Terbutaline—Epinephrine—TNF—type 2 diabetes mellitus	0.000432	0.0253	CrCbGaD
Terbutaline—Nausea—Ramipril—type 2 diabetes mellitus	0.000411	0.00107	CcSEcCtD
Terbutaline—Epinephrine—CYP1A2—type 2 diabetes mellitus	0.000317	0.0185	CrCbGaD
Terbutaline—Epinephrine—CYP3A4—type 2 diabetes mellitus	0.00021	0.0123	CrCbGaD
Terbutaline—BCHE—Metabolism—HBA2—type 2 diabetes mellitus	0.000152	0.00133	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—G6PC—type 2 diabetes mellitus	0.000152	0.00133	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PPP1R3C—type 2 diabetes mellitus	0.000152	0.00133	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ENPP1—type 2 diabetes mellitus	0.000152	0.00133	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ND1—type 2 diabetes mellitus	0.000152	0.00133	CbGpPWpGaD
Terbutaline—BCHE—Neuronal System—PRKCB—type 2 diabetes mellitus	0.000149	0.0013	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GCGR—type 2 diabetes mellitus	0.000147	0.00129	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR5—type 2 diabetes mellitus	0.000145	0.00127	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—ADRB3—type 2 diabetes mellitus	0.000145	0.00127	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—F7—type 2 diabetes mellitus	0.000144	0.00126	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—C3—type 2 diabetes mellitus	0.000142	0.00124	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	0.000141	0.00124	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—PAX6—type 2 diabetes mellitus	0.00014	0.00122	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—CRHR1—type 2 diabetes mellitus	0.00014	0.00122	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—OXCT1—type 2 diabetes mellitus	0.000139	0.00121	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CYTB—type 2 diabetes mellitus	0.000139	0.00121	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—SRD5A1—type 2 diabetes mellitus	0.000135	0.00118	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGT—type 2 diabetes mellitus	0.000135	0.00118	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—GNB3—type 2 diabetes mellitus	0.000132	0.00115	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—ADRB3—type 2 diabetes mellitus	0.000132	0.00115	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MTNR1A—type 2 diabetes mellitus	0.000131	0.00114	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—AVP—type 2 diabetes mellitus	0.00013	0.00114	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ACACA—type 2 diabetes mellitus	0.000129	0.00113	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—HSD17B3—type 2 diabetes mellitus	0.000129	0.00113	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—STAR—type 2 diabetes mellitus	0.000129	0.00113	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—GHRL—type 2 diabetes mellitus	0.000128	0.00112	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—MTNR1B—type 2 diabetes mellitus	0.000128	0.00112	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—CRHR1—type 2 diabetes mellitus	0.000127	0.00111	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—GLP1R—type 2 diabetes mellitus	0.000125	0.00109	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—ACE—type 2 diabetes mellitus	0.000124	0.00109	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—EDN1—type 2 diabetes mellitus	0.000124	0.00108	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ABCC8—type 2 diabetes mellitus	0.000124	0.00108	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CBS—type 2 diabetes mellitus	0.000124	0.00108	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—CCKAR—type 2 diabetes mellitus	0.000123	0.00107	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—TCF7L2—type 2 diabetes mellitus	0.000119	0.00104	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—COX2—type 2 diabetes mellitus	0.000119	0.00104	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—SLC5A2—type 2 diabetes mellitus	0.000119	0.00104	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—GCG—type 2 diabetes mellitus	0.000117	0.00102	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—NCOA6—type 2 diabetes mellitus	0.000117	0.00102	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	0.000117	0.00102	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—MTNR1B—type 2 diabetes mellitus	0.000116	0.00102	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—UCP2—type 2 diabetes mellitus	0.000115	0.00101	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—HSD11B1—type 2 diabetes mellitus	0.000115	0.00101	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—UCP3—type 2 diabetes mellitus	0.000115	0.00101	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—GLP1R—type 2 diabetes mellitus	0.000113	0.00099	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—GCGR—type 2 diabetes mellitus	0.000113	0.000987	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	0.000111	0.000975	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—CCKAR—type 2 diabetes mellitus	0.000111	0.000974	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—type 2 diabetes mellitus	0.000111	0.000971	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—CCR5—type 2 diabetes mellitus	0.000111	0.000967	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—IAPP—type 2 diabetes mellitus	0.00011	0.000966	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PCK1—type 2 diabetes mellitus	0.000108	0.000946	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—C3—type 2 diabetes mellitus	0.000108	0.000945	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—TRPC6—type 2 diabetes mellitus	0.000108	0.000943	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—AGTR2—type 2 diabetes mellitus	0.000107	0.000938	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	0.000106	0.000931	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	0.000104	0.000908	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—GRK5—type 2 diabetes mellitus	0.000104	0.000908	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—GIPR—type 2 diabetes mellitus	0.000104	0.000908	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—EDNRB—type 2 diabetes mellitus	0.000103	0.000898	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—AGT—type 2 diabetes mellitus	0.000103	0.000898	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—HK1—type 2 diabetes mellitus	0.000101	0.000885	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	0.000101	0.000884	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—GNB3—type 2 diabetes mellitus	0.000101	0.000883	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—IAPP—type 2 diabetes mellitus	0.0001	0.000877	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—HTR2C—type 2 diabetes mellitus	9.97e-05	0.000872	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—IGF2—type 2 diabetes mellitus	9.92e-05	0.000868	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	9.8e-05	0.000857	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—KCNJ11—type 2 diabetes mellitus	9.78e-05	0.000855	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GCKR—type 2 diabetes mellitus	9.78e-05	0.000855	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—LPA—type 2 diabetes mellitus	9.78e-05	0.000855	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—HSD3B2—type 2 diabetes mellitus	9.78e-05	0.000855	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	9.74e-05	0.000852	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	9.7e-05	0.000848	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MC4R—type 2 diabetes mellitus	9.5e-05	0.00083	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	9.49e-05	0.00083	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	9.45e-05	0.000827	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	9.4e-05	0.000822	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ALDOB—type 2 diabetes mellitus	9.38e-05	0.00082	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	9.34e-05	0.000816	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	9.33e-05	0.000816	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—GIP—type 2 diabetes mellitus	9.14e-05	0.000799	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	9.11e-05	0.000796	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	9.06e-05	0.000792	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	8.92e-05	0.00078	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	8.82e-05	0.000771	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	8.81e-05	0.00077	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GLP1R—type 2 diabetes mellitus	8.72e-05	0.000762	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—LEPR—type 2 diabetes mellitus	8.69e-05	0.00076	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—GCG—type 2 diabetes mellitus	8.65e-05	0.000756	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	8.62e-05	0.000754	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—GHRL—type 2 diabetes mellitus	8.58e-05	0.000751	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	8.51e-05	0.000744	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—CALCA—type 2 diabetes mellitus	8.48e-05	0.000741	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—CCL2—type 2 diabetes mellitus	8.46e-05	0.00074	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	8.3e-05	0.000726	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—SLC2A2—type 2 diabetes mellitus	8.14e-05	0.000712	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—TLE4—type 2 diabetes mellitus	8.08e-05	0.000706	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—MTR—type 2 diabetes mellitus	7.97e-05	0.000697	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CPT1A—type 2 diabetes mellitus	7.97e-05	0.000697	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—MMP1—type 2 diabetes mellitus	7.97e-05	0.000697	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—AGT—type 2 diabetes mellitus	7.87e-05	0.000688	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—GCG—type 2 diabetes mellitus	7.85e-05	0.000687	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—NAMPT—type 2 diabetes mellitus	7.82e-05	0.000684	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—ADRB3—type 2 diabetes mellitus	7.77e-05	0.00068	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	7.77e-05	0.00068	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GCK—type 2 diabetes mellitus	7.77e-05	0.000679	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—LIPC—type 2 diabetes mellitus	7.77e-05	0.000679	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—HBA1—type 2 diabetes mellitus	7.77e-05	0.000679	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	7.72e-05	0.000675	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CYP11A1—type 2 diabetes mellitus	7.72e-05	0.000675	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—LEP—type 2 diabetes mellitus	7.71e-05	0.000674	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—SLC9A1—type 2 diabetes mellitus	7.58e-05	0.000663	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CRHR1—type 2 diabetes mellitus	7.51e-05	0.000656	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CETP—type 2 diabetes mellitus	7.49e-05	0.000655	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	7.45e-05	0.000652	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—AVP—type 2 diabetes mellitus	7.35e-05	0.000643	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	6.99e-05	0.000611	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	6.99e-05	0.000611	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—SREBF1—type 2 diabetes mellitus	6.97e-05	0.000609	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PSMD6—type 2 diabetes mellitus	6.97e-05	0.000609	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—SNAP25—type 2 diabetes mellitus	6.97e-05	0.000609	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	6.93e-05	0.000606	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	6.87e-05	0.0006	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—SPRY2—type 2 diabetes mellitus	6.87e-05	0.0006	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CTGF—type 2 diabetes mellitus	6.84e-05	0.000598	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—HMGCR—type 2 diabetes mellitus	6.78e-05	0.000593	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—GNB3—type 2 diabetes mellitus	6.77e-05	0.000592	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—RBP4—type 2 diabetes mellitus	6.69e-05	0.000585	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—GLP1R—type 2 diabetes mellitus	6.69e-05	0.000585	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	6.68e-05	0.000585	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—MMP3—type 2 diabetes mellitus	6.68e-05	0.000584	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—AVP—type 2 diabetes mellitus	6.68e-05	0.000584	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	6.64e-05	0.000581	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ADRA2A—type 2 diabetes mellitus	6.63e-05	0.00058	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—INS—type 2 diabetes mellitus	6.59e-05	0.000576	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CCKAR—type 2 diabetes mellitus	6.58e-05	0.000576	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—CCL2—type 2 diabetes mellitus	6.48e-05	0.000567	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CYP2E1—type 2 diabetes mellitus	6.37e-05	0.000557	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—IGF1—type 2 diabetes mellitus	6.37e-05	0.000557	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—EDN1—type 2 diabetes mellitus	6.35e-05	0.000555	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—SLC2A1—type 2 diabetes mellitus	6.3e-05	0.000551	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CYP1A2—type 2 diabetes mellitus	6.3e-05	0.000551	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	6.25e-05	0.000547	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CYP3A4—type 2 diabetes mellitus	6.14e-05	0.000537	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	6.11e-05	0.000535	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—C3—type 2 diabetes mellitus	6.11e-05	0.000534	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GCG—type 2 diabetes mellitus	6.04e-05	0.000528	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—SLC2A4—type 2 diabetes mellitus	6.04e-05	0.000528	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	6.03e-05	0.000527	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	5.96e-05	0.000521	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—IAPP—type 2 diabetes mellitus	5.93e-05	0.000518	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—INSR—type 2 diabetes mellitus	5.89e-05	0.000515	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—AGT—type 2 diabetes mellitus	5.8e-05	0.000508	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—TRPC6—type 2 diabetes mellitus	5.79e-05	0.000506	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	5.78e-05	0.000505	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—AGTR2—type 2 diabetes mellitus	5.75e-05	0.000503	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—CCR5—type 2 diabetes mellitus	5.68e-05	0.000496	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—C3—type 2 diabetes mellitus	5.55e-05	0.000485	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—EDNRB—type 2 diabetes mellitus	5.51e-05	0.000482	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	5.36e-05	0.000469	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	5.35e-05	0.000468	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	5.35e-05	0.000468	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—AGT—type 2 diabetes mellitus	5.27e-05	0.000461	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.21e-05	0.000455	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GNB3—type 2 diabetes mellitus	5.21e-05	0.000455	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	5.2e-05	0.000455	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—HMOX1—type 2 diabetes mellitus	5.18e-05	0.000453	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	5.18e-05	0.000453	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CYBA—type 2 diabetes mellitus	5.18e-05	0.000453	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CAT—type 2 diabetes mellitus	5.11e-05	0.000447	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	5.09e-05	0.000445	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—GHRL—type 2 diabetes mellitus	5.07e-05	0.000443	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PLAT—type 2 diabetes mellitus	5.07e-05	0.000443	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CALCA—type 2 diabetes mellitus	5.01e-05	0.000438	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—APOB—type 2 diabetes mellitus	4.96e-05	0.000434	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	4.87e-05	0.000426	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GSTM1—type 2 diabetes mellitus	4.83e-05	0.000422	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—LPL—type 2 diabetes mellitus	4.74e-05	0.000415	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	4.72e-05	0.000413	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	4.7e-05	0.000411	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ADCY5—type 2 diabetes mellitus	4.64e-05	0.000406	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	4.64e-05	0.000406	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—GCG—type 2 diabetes mellitus	4.64e-05	0.000406	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GPX1—type 2 diabetes mellitus	4.63e-05	0.000404	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	4.56e-05	0.000399	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	4.55e-05	0.000398	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CD36—type 2 diabetes mellitus	4.5e-05	0.000394	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PPP2CA—type 2 diabetes mellitus	4.45e-05	0.000389	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	4.34e-05	0.00038	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—MTHFR—type 2 diabetes mellitus	4.27e-05	0.000373	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	4.26e-05	0.000373	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	4.26e-05	0.000373	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PPARA—type 2 diabetes mellitus	4.19e-05	0.000366	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—AGT—type 2 diabetes mellitus	4.06e-05	0.000355	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	4.03e-05	0.000353	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—GNB3—type 2 diabetes mellitus	4e-05	0.00035	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CALM1—type 2 diabetes mellitus	3.99e-05	0.000349	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—APOE—type 2 diabetes mellitus	3.97e-05	0.000347	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—AVP—type 2 diabetes mellitus	3.94e-05	0.000345	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MMP3—type 2 diabetes mellitus	3.94e-05	0.000345	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—APOA1—type 2 diabetes mellitus	3.93e-05	0.000343	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—IGF2—type 2 diabetes mellitus	3.93e-05	0.000343	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	3.91e-05	0.000342	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	3.87e-05	0.000338	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—APOB—type 2 diabetes mellitus	3.81e-05	0.000333	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	3.8e-05	0.000332	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—EDN1—type 2 diabetes mellitus	3.75e-05	0.000328	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—LPL—type 2 diabetes mellitus	3.64e-05	0.000318	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.56e-05	0.000312	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PPARG—type 2 diabetes mellitus	3.46e-05	0.000303	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.41e-05	0.000299	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—INS—type 2 diabetes mellitus	3.39e-05	0.000297	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.35e-05	0.000293	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—C3—type 2 diabetes mellitus	3.28e-05	0.000287	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.13e-05	0.000273	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.12e-05	0.000273	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—AGT—type 2 diabetes mellitus	3.11e-05	0.000272	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ALB—type 2 diabetes mellitus	3.11e-05	0.000272	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.06e-05	0.000268	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—LEP—type 2 diabetes mellitus	3.05e-05	0.000267	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—APOE—type 2 diabetes mellitus	3.05e-05	0.000267	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.02e-05	0.000264	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—NOS3—type 2 diabetes mellitus	2.98e-05	0.00026	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PIK3R1—type 2 diabetes mellitus	2.98e-05	0.00026	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.88e-05	0.000252	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PTGS2—type 2 diabetes mellitus	2.72e-05	0.000238	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.72e-05	0.000238	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—INS—type 2 diabetes mellitus	2.61e-05	0.000228	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.56e-05	0.000224	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.52e-05	0.00022	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.52e-05	0.00022	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.51e-05	0.000219	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.39e-05	0.000209	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.29e-05	0.0002	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.29e-05	0.0002	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—RELA—type 2 diabetes mellitus	2.15e-05	0.000188	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.96e-05	0.000171	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.94e-05	0.00017	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.93e-05	0.000169	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.83e-05	0.00016	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.81e-05	0.000159	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.78e-05	0.000156	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.69e-05	0.000148	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.65e-05	0.000144	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.51e-05	0.000132	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.48e-05	0.00013	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—AKT1—type 2 diabetes mellitus	1.37e-05	0.00012	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—IL6—type 2 diabetes mellitus	1.14e-05	9.96e-05	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.05e-05	9.19e-05	CbGpPWpGaD
